Autres langues Colinz Laboratories Limited

Actions

531210

INE923C01011

Produits pharmaceutiques

Marché Fermé - Bombay S.E. 12:02:28 29/09/2026			Varia. 5j.	Varia. 1 janv.
74,96 ^INR	+0,35 %		+0,13 %	+39,77 %

20/08	Annjana Dugar, Likhitta Dugar et Antariksh Dugar ont finalisé l'acquisition d'une participation supplémentaire de 0,000238% dans Colinz Laboratories Limited (BSE:531210) pour 0,000324 million INR.	CI
30/07	Colinz Laboratories Limited publie ses résultats pour le premier trimestre clos le 30 juin 2026	CI

Autres langues

20/08	Annjana Dugar, Likhitta Dugar and Antariksh Dugar completed the acquisition of an additional 0.000238% stake in Colinz Laboratories Limited for INR 324.
30/07	Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
18/06	Annjana Dugar, Likhitta Dugar and Antariksh Dugar executed of Share Purchase Agreement to acquire an additional 34.56% stake in Colinz Laboratories Limited from Vijaya Mani for INR 43.5 million.
18/06	Annjana Dugar, Likhitta Dugar and Antariksh Dugar proposed to acquire an additional 26% stake in Colinz Laboratories Limited for INR 35.4 million.
25/05	Padam Dugar, Annjana Dugar, Likhitta Dugar and Antariksh Dugar acquired 15.01% stake in Colinz Laboratories Limited.
29/04	Colinz Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
24/01	Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
17/01	Hilsun Foods And Drugs Private Limited signed a letter of intent to acquire Factory Building, Factory Machinery, & Factory Land of Colinz Laboratories Limited for INR 40 million.
27/11	Colinz Laboratories Limited Appoints Falguni Kumawat as Company Secretary and Compliance Officer, with Effect from 1 December, 2025
08/11	Colinz Laboratories Limited Announces of Demise Dr. Mani L.S., Founder Director, Company Secretary and Compliance Officer on 7 November 2025
03/11	Colinz Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
31/07/25	Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
21/05/25	Colinz Laboratories Limited Appoints Swapnil Jayesh Madiyar as Additional Director, Effective from May 16, 2025
16/05/25	Colinz Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025
04/03/25	Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024
30/10/24	Colinz Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
01/10/24	Colinz Laboratories Limited Approves Board Appointments
08/08/24	Colinz Laboratories Limited Announces Cessation of Board of Directors, Effective 30 September 2024
31/07/24	Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024
29/05/24	Colinz Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
29/05/24	Colinz Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
31/01/24	Colinz Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
29/08/23	Colinz Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023
30/07/22	Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
28/05/22	Colinz Laboratories Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022